Description

Indications

Tobra 5ml Eye Drop is primarily indicated in conditions like Bacterial infections, Biliary tract infections, Chronic pulmonary pseudomonas aeruginosa infection in cystic fibrosis patients, Cystic fibrosis, Endocarditis, Eye infections, Gram +ve (some) and gram -ve (many) infections, Heart failure, Iron deficiency anaemia, NSAID-associated ulceration, Oliguria due to renal failure, Pneumonia in hospital patients, Prohylaxis of stress ulceration, Respiratory tract infections, Septicaemia, Supraventricular arrhythmias (particularly atrial fibrillation), Symptoms associated with carcinoid tumours, Trauma, Ulcerative colitis and crohn’s disease, Urinary tract infection, UTI.

Side Effects

The severe or irreversible adverse effects of Tobra 5ml Eye Drop , which give rise to further complications include Ototoxicity, Elevation in serum creatinine, Neuromuscular blockage. Tobra 5ml Eye Drop produces potentially life-threatening effects which include Nephrotoxicity, Dehydration, Proteinuria, Oliguria, Hyperuricemia. which are responsible for the discontinuation of Tobra 5ml Eye Drop therapy. The symptomatic adverse reactions produced by Tobra 5ml Eye Drop are more or less tolerable and if they become severe, they can be treated symptomatically, these include Skin reactions, Maculopapular rash, Urticaria, Local pain, Phlebitis.

 Warnings

Tobra 5ml Eye Drop should be used with caution in patients with history of kidney diseases, vertigo, hearing loss, myasthenia gravis, parkinsonisms. It should be used with caution in patients who are sensitive to aminoglycosides. Perform monthly blood counts test for atleast 4 months. Keep patients well hydrated to prevent chemical irritation or nephrotoxic reactions. Take appropriate measures in case of secondary infections.